ADAM19 and breast carcinoma: Previous mechanistic research has shown that miR-145 could regulate cell proliferation by targeting TGF-β1 in breast cancer (Ding et al., 2017), by targeting NRAS in condyloma acuminatum (Liu et al., 2018), and by regulating ADAM19 in retinoblastoma (Sun et al., 2015).